Your browser doesn't support javascript.
loading
A core outcome set for studies of gestational diabetes mellitus prevention and treatment.
Egan, Aoife M; Bogdanet, Delia; Griffin, Tomás P; Kgosidialwa, Oratile; Cervar-Zivkovic, Mila; Dempsey, Eugene; Allotey, John; Alvarado, Fernanda; Clarson, Cheril; Cooray, Shamil D; de Valk, Harold W; Galjaard, Sander; Loeken, Mary R; Maresh, Michael J A; Napoli, Angela; O'Shea, Paula M; Wender-Ozegowska, Ewa; van Poppel, Mireille N M; Thangaratinam, Shakila; Crowther, Caroline; Biesty, Linda M; Devane, Declan; Dunne, Fidelma P.
Afiliação
  • Egan AM; Division of Endocrinology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. egan.aoife@mayo.edu.
  • Bogdanet D; School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Griffin TP; School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Kgosidialwa O; Department of Endocrinology, St Vincent's University Hospital, Dublin, Ireland.
  • Cervar-Zivkovic M; School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Dempsey E; Division of Obstetrics, Medizinische Universitat Graz, Graz, Austria.
  • Allotey J; INFANT Centre and Department of Paediatrics & Child Health, University College Cork, Cork, Ireland.
  • Alvarado F; Barts Research Centre for Women's Health (BARC), Women's Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Clarson C; Mother Infant Research Institute, Tufts Medical Center, Boston, MA, USA.
  • Cooray SD; Department of Pediatrics, University of Western Ontario, London, ON, Canada.
  • de Valk HW; Lawson Health Research Institute, London, ON, Canada.
  • Galjaard S; Barts Research Centre for Women's Health (BARC), Women's Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Loeken MR; Diabetes and Vascular Medicine Unit, Monash Health, Melbourne, VIC, Australia.
  • Maresh MJA; Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC, Australia.
  • Napoli A; Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • O'Shea PM; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, the Netherlands. s.galjaard@erasmusmc.nl.
  • Wender-Ozegowska E; Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
  • van Poppel MNM; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Thangaratinam S; Department of Obstetrics, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Crowther C; Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza, University of Rome, Rome, Italy.
  • Biesty LM; School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Devane D; Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland.
  • Dunne FP; Institute of Sport Science, University of Graz, Graz, Austria.
Diabetologia ; 63(6): 1120-1127, 2020 06.
Article em En | MEDLINE | ID: mdl-32193573
ABSTRACT
AIMS/

HYPOTHESIS:

The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM).

METHODS:

We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised.

RESULTS:

Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). CONCLUSIONS/

INTERPRETATION:

This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. TRIAL REGISTRATION This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database http//www.comet-initiative.org/studies/details/686/.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos